1. Home
  2. HCM vs SPNT Comparison

HCM vs SPNT Comparison

Compare HCM & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • SPNT
  • Stock Information
  • Founded
  • HCM 2000
  • SPNT 2011
  • Country
  • HCM Hong Kong
  • SPNT Bermuda
  • Employees
  • HCM N/A
  • SPNT N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • SPNT Property-Casualty Insurers
  • Sector
  • HCM Health Care
  • SPNT Finance
  • Exchange
  • HCM Nasdaq
  • SPNT Nasdaq
  • Market Cap
  • HCM 2.5B
  • SPNT 2.2B
  • IPO Year
  • HCM N/A
  • SPNT N/A
  • Fundamental
  • Price
  • HCM $14.84
  • SPNT $19.28
  • Analyst Decision
  • HCM Hold
  • SPNT Hold
  • Analyst Count
  • HCM 1
  • SPNT 1
  • Target Price
  • HCM $19.00
  • SPNT $17.00
  • AVG Volume (30 Days)
  • HCM 90.6K
  • SPNT 525.3K
  • Earning Date
  • HCM 07-30-2025
  • SPNT 07-31-2025
  • Dividend Yield
  • HCM N/A
  • SPNT N/A
  • EPS Growth
  • HCM N/A
  • SPNT N/A
  • EPS
  • HCM 0.04
  • SPNT 0.96
  • Revenue
  • HCM $630,201,000.00
  • SPNT $2,682,300,000.00
  • Revenue This Year
  • HCM $14.86
  • SPNT $11.96
  • Revenue Next Year
  • HCM $19.54
  • SPNT $6.66
  • P/E Ratio
  • HCM $66.84
  • SPNT $20.13
  • Revenue Growth
  • HCM N/A
  • SPNT N/A
  • 52 Week Low
  • HCM $11.51
  • SPNT $11.96
  • 52 Week High
  • HCM $21.50
  • SPNT $20.00
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.89
  • SPNT 52.99
  • Support Level
  • HCM $15.02
  • SPNT $18.96
  • Resistance Level
  • HCM $18.00
  • SPNT $20.00
  • Average True Range (ATR)
  • HCM 0.42
  • SPNT 0.51
  • MACD
  • HCM -0.04
  • SPNT -0.09
  • Stochastic Oscillator
  • HCM 31.45
  • SPNT 44.62

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: